Liang Qing, Chang Yanhua, Liu Jing, Yu Yan, Qiu Wancheng, Li Jiajia, Yang Xu, Sun Guangchun
Department of Pharmacy, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Department of Pathology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Front Pharmacol. 2021 Jul 19;12:678733. doi: 10.3389/fphar.2021.678733. eCollection 2021.
Pulmonary fibrosis is a kind of interstitial lung disease with progressive pulmonary scar formation, leading to irreversible loss of lung functions. The TGF-β1/Smad signaling pathway plays a key role in fibrogenic processes. It is associated with the increased synthesis of extracellular matrix, enhanced proliferation of fibroblasts, and transformation of alveolar epithelial cells into interstitial cells. We investigated P-Rex1, a PIP-Gβγ-dependent guanine nucleotide exchange factor (GEF) for Rac, for its potential role in TGF-β1-induced pulmonary fibrosis. A high expression level of P-Rex1 was identified in the lung tissue of patients with pulmonary fibrosis than that from healthy donors. Using the P-Rex1 knockdown and overexpression system, we established a novel player of P-Rex1 in mouse lung fibroblast migration. P-Rex1 contributed to fibrogenic processes in lung fibroblasts by targeting the TGF-β type Ⅱ receptor (TGFβR2). The RNA-seq analysis for expression profiling confirmed the modulation of P-Rex1 in cell migration and the involvement of P-Rex1 in TGF-β1 signaling. These results identified P-Rex1 as a signaling molecule involved in TGF-β1-induced pulmonary fibrosis, suggesting that P-Rex1 may be a potential target for pulmonary fibrosis treatment.
肺纤维化是一种伴有进行性肺瘢痕形成的间质性肺疾病,会导致肺功能不可逆转的丧失。转化生长因子-β1(TGF-β1)/Smad信号通路在纤维化过程中起关键作用。它与细胞外基质合成增加、成纤维细胞增殖增强以及肺泡上皮细胞向间质细胞转化有关。我们研究了P-Rex1,一种Rac的PIP-Gβγ依赖性鸟嘌呤核苷酸交换因子(GEF),以探讨其在TGF-β1诱导的肺纤维化中的潜在作用。与健康供体相比,肺纤维化患者肺组织中P-Rex1表达水平较高。利用P-Rex1基因敲低和过表达系统,我们确定了P-Rex1在小鼠肺成纤维细胞迁移中的新作用。P-Rex1通过靶向Ⅱ型TGF-β受体(TGFβR2)促进肺成纤维细胞的纤维化过程。RNA测序表达谱分析证实了P-Rex1在细胞迁移中的调节作用以及P-Rex1参与TGF-β1信号传导。这些结果确定P-Rex1是参与TGF-β1诱导的肺纤维化的信号分子,表明P-Rex1可能是肺纤维化治疗的潜在靶点。